1: (ROOT (S (NP (NP (NNP Cedar) (HYPH -) (NNP Sinai)) (S (VP (TO To) (VB Use) (NP (NNP UV) (NN Light)) (TO To) (VB Treat) (NP (NN COVI-19Ultraviolet) (NN therapy))))) (VP (MD may) (VP (VB be) (VP (VBG coming) (PP (IN to) (NP (NP (DT a) (NN hospital)) (PP (IN near) (NP (PRP you))))) (S (VP (TO to) (VP (VB help) (VP (VB treat) (NP (NP (CD COVI-19)) (VP (VBN developed) (PP (IN by) (NP (NP (NML (NNP Cedar) (HYPH -) (NNP Sinai)) (NN hospital)) (PP (IN in) (NP (NNP Los) (NNP Angeles)))))))))))))) (. .)))
2: (ROOT (S (NP (NNP Healight) (NNP Platform) (NNP Technology)) (VP (VBZ has) (VP (VBN been) (ADVP (RB exclusively)) (VP (VBN licensed) (PP (IN to) (NP (NNP Aytu) (NNP BioScience) (NNP Inc))) (PP (PP (IN for) (NP (JJ worldwide) (JJ commercial) (NN development) (CC and) (NN release))) (SBAR (WHNP (WDT which)) (S (VP (MD could) (VP (VB mean) (SBAR (IN that) (S (NP (NP (NNS hospitals)) (PP (IN around) (NP (DT the) (NN globe)))) (VP (MD may) (ADVP (RB soon)) (VP (VB adopt) (NP (DT this) (NN approach)))))))))))))) (. .)))
3: (ROOT (S (PP (VBG According) (PP (IN to) (NP (DT some) (NNS reports)))) (NP (DT this) (NN method)) (VP (VBZ has) (VP (VBN been) (VP (VBN billed) (PP (IN as) (S (VP (VBG being) (NP (NP (NP (DT a) (JJ potential) (`` `) (NML (NN firs) (HYPH -) (FW i) (HYPH -) (NN class)) (NN treatment)) (PP (IN for) (NP (NP (NN coronavirus)) (CC and) (NP (JJ other) (JJ respiratory) (NNS infections))))) (, ,) ('' ') (SBAR (WHNP (WDT that)) (S (VP (VBZ utilizes) (NP (NP (JJ proprietary) (NNS methods)) (PP (IN of) (S (VP (VBG administering) (NP (JJ intermittent) (NNP UVA) (NN light)) (S (VP (VBG using) (NP (DT a) (JJ novel) (JJ endotracheal) (NN device)))))))))))))))))) (. .)))
4: (ROOT (S (NP (JJ Preclinical) (NN study) (NNS findings)) (VP (VBP are) (VP (VBG suggesting) (SBAR (IN that) (S (NP (DT this) (NN approach)) (VP (VBZ has) (NP (NP (DT the) (NN potential) (S (VP (TO to) (VP (VB help) (S (VP (VB eradicate) (NP (NP (DT the) (NN spread)) (PP (IN of) (NP (DT this) (CD COVI-19) (NN outbreak)))))))))) (, ,) (CONJP (CONJP (RB as) (RB well) (IN as)) (`` `)) (NP (NP (DT a) (JJ wide) (NN range)) (PP (IN of) (NP (NNS viruses) (CC and) (NNS bacteria))) (, ,) (ADJP (JJ inclusive) (PP (IN of) (NP (NN coronavirus))))))))))) (. .) ('' ')))
5: (ROOT (S (S (NP (NP (NP (DT A) (NN team)) (PP (IN from) (NP (NP (DT the) (ADJP (NNP Medically) (NNP Associated)) (NML (NNP Science) (CC and) (NNP Technology)) (NNP Program)) (PP (IN at) (NP (NNP Cedar) (HYPH -) (NNP Sinai)))))) (VP (VBN led) (PP (IN by) (NP (NP (NNP D.) (NNP Mark) (NNP Pimental)) (, ,) (NP (NNP MD)))))) (VP (VBP have) (VP (VBN been) (VP (VBG developing) (NP (NNP Healight)) (PP (IN since) (NP (CD 2016))))))) (, ,) (CC and) (S (NP (PRP it)) (VP (VBZ has) (NP (NP (DT a) (VBG growing) (NN body)) (PP (IN of) (NP (NP (NN evidence)) (VP (VBG demonstrating) (NP (NP (PRP$ its) (NN efficacy)) (PP (IN as) (NP (DT both) (NP (DT an) (JJ antiviral)) (CC and) (NP (DT an) (JJ antibacterial) (NN treatment))))))))))) (. .)))
6: (ROOT (S (S (NP (EX There)) (VP (VBP have) (VP (VBN been) (NP (NP (NNS rumors)) (PP (IN of) (NP (NP (NNS talks)) (PP (IN with) (NP (DT the) (NNP FDA))) (PP (IN about) (NP (NP (DT the) (NN development)) (PP (IN of) (NP (NP (DT a) (NML (JJ near) (NN term)) (NN path)) (SBAR (WHNP (WDT that)) (S (VP (MD could) (VP (VB enable) (NP (NP (JJ early) (NN use)) (PP (IN of) (NP (DT this) (NN technology))) (S (VP (TO to) (VP (VB help) (NP (NP (DT the) (HYPH COVI-19) (NNS patients)) (SBAR (WHNP (WP who)) (S (VP (VBP are) (VP (VBG suffering) (PP (IN in) (NP (NNS ICUs)))))))))))))))))))))))))) (, ,) (CC and) (S (NP (PRP it)) (VP (MD may) (ADVP (RB also)) (VP (VB be) (ADJP (JJ useful) (PP (IN in) (S (VP (VBG treating) (NP (NP (ADJP (NN ventilator) (VBN associated)) (NN pneumonia)) (, ,) (CC or) (NP (NNP VAP)))))))))) (. .)))
7: (ROOT (SINV ('' `) (S (NP (PRP$ Our) (NN team)) (VP (VBZ has) (VP (VBN shown) (SBAR (IN that) (S (S (VP (VBG administering) (NP (NP (DT a) (JJ specific) (NN spectrum)) (PP (IN of) (NP (NML (NNP U) (HYPH -) (NN A)) (NN light)))))) (VP (MD can) (VP (VB eradicate) (NP (NP (NP (NNS viruses)) (PP (IN in) (NP (JJ infected) (JJ human) (NNS cells)))) (CC and) (NP (NP (NNS bacteria)) (PP (IN in) (NP (DT the) (NN area))))) (SBAR (IN while) (S (VP (VBG preserving) (NP (JJ healthy) (NNS cells)))))))))))) (, ,) ('' ') (VP (VBD stated)) (NP (NP (NNP D.) (NNP Pimentel)) (PP (IN of) (NP (NNP Cedar) (HYPH -) (NNP Sinai)))) (. .)))
8: (ROOT (S (S (NP (NP (NNP Ali) (NNP Rezaie)) (, ,) (NP (NNP MD)) (, ,) (NP (NP (CD one)) (PP (IN of) (NP (NP (DT the) (NNS inventors)) (PP (IN of) (NP (DT this) (NN technology))))))) (VP (VBZ states))) (, ,) (`` `) (S (NP (NP (PRP$ Our) (NN lab)) (PP (IN at) (NP (NNP Cedar) (HYPH -) (NNP Sinai)))) (VP (VBZ has) (ADVP (RB extensively)) (VP (VBN studied) (NP (NP (DT the) (NNS effects)) (PP (IN of) (NP (DT this) (JJ unique) (NN technology))) (PP (IN on) (NP (NNS bacteria) (CC and) (NNS viruses))))))) (. .)))
9: (ROOT (S (PP (VBN Based) (PP (IN on) (NP (PRP$ our) (NNS findings)))) (NP (PRP we)) (VP (VBP believe) (SBAR (S (NP (DT this) (JJ therapeutic) (NN approach)) (VP (VBZ has) (NP (DT the) (NN potential) (S (VP (TO to) (ADVP (RB significantly)) (VP (VB impact) (NP (NP (DT the) (JJ high) (NN morbidity) (CC and) (NN mortality)) (PP (IN of) (NP (NP (ADJP (NN coronaviru) (HYPH -) (VBN infected)) (NNS patients)) (CC and) (NP (NP (NNS patients)) (VP (VBN infected) (PP (IN with) (NP (JJ other) (JJ respiratory) (NNS pathogens)))))))))))))))) (. .)))
10: (ROOT (S (NP (PRP We)) (VP (VBP are) (VP (VBG looking) (PRT (RP forward)) (PP (IN to) (S (VP (VBG partnering) (PP (IN with) (NP (NNP Aytu) (NNP BioScience))) (S (VP (TO to) (VP (VB move) (NP (DT this) (NN technology)) (ADVP (RB forward)) (PP (IN for) (NP (NP (DT the) (NN benefit)) (PP (IN of) (NP (NP (NNS patients)) (PP (ADVP (DT all)) (IN over) (NP (DT the) (NN world))))))))))))))) (. .) ('' ')))
11: (ROOT (S (NP (NP (DT The) (NNP FDA)) (, ,) (NP (NNP Aytu)) (, ,) (CC and) (NP (NNP Cedar) (HYPH -) (NNP Sinai))) (VP (VBP are) (VP (VBN rumored) (S (VP (TO to) (VP (VB be) (VP (VBG working) (ADVP (RB together)) (PP (IN towards) (S (VP (VBG developing) (NP (NP (DT a) (NN plan)) (PP (IN for) (NP (NP (NP (DT the) (JJ expedited) (JJ regulatory) (NN approval)) (PP (IN of) (NP (NNP Healight)))) (SBAR (S (VP (TO to) (VP (VB be) (VP (VBN used) (PP (IN against) (NP (NP (DT the) (JJ continued) (NN battle)) (PP (IN against) (NP (DT the) (JJ global) (CD COVI-19) (NN outbreak)))))))))))))))))))))) (. .)))
12: (ROOT (S (NP (DT Those) (ADJP (JJ critical) (JJ ill) (PP (IN with) (NP (DT this) (NN virus))))) (VP (MD may) (VP (VB benefit) (PP (IN from) (NP (NP (NN use)) (PP (IN of) (NP (DT this) (ADJP (RB minimally) (JJ invasive)) (NN treatment) (NN approach))))))) (. .)))
13: (ROOT (S (PP (IN Around) (NP (DT the) (NN globe))) (NP (JJ many) (NNS hospitals)) (VP (VBP are) (ADVP (RB already)) (VP (VBG using) (NP (NN UV) (NN light)) (S (VP (TO to) (VP (VB help) (S (VP (VP (VB clean) (NP (NNS surfaces))) (CC and) (VP (VB disinfect) (NP (NP (NNS rooms)) (SBAR (WHADVP (WRB where)) (S (NP (HYPH COVI-19) (NNS patients)) (VP (VBP have) (VP (VBN been) (VP (VBN treated))))))))))))))) (, ,) (S (S (VP (VBG extending) (NP (NP (DT the) (NN use)) (PP (IN of) (NP (JJ such) (NN technology)))) (PP (IN to) (NP (NP (DT the) (JJ direct) (NN treatment)) (PP (IN of) (NP (DT the) (NN virus))) (PP (IN in) (NP (NNS patients))))))) (VP (MD would) (VP (VB appear) (S (VP (TO to) (VP (VB be) (NP (DT the) (JJ next) (JJ logical) (NN step)))))))) (. .)))
14: (ROOT (S (S (S (NP (NP (JJ Natural) (NN UV) (NN light)) (PP (IN from) (NP (DT the) (NN sun)))) (VP (VBZ appears) (S (VP (TO to) (VP (VB be) (ADJP (JJ able) (S (VP (TO to) (VP (VB destroy) (NP (NP (NP (ADJP (RBS most) (JJ harmful)) (NNS bacteria)) (PP (IN on) (NP (DT the) (NN skin)))) (CONJP (RB as) (RB well) (IN as)) (NP (NP (NNS viruses)) (CC and) (NP (JJ other) (NNS microbes))))))))))))) (, ,) (S (NP (JJ similar) (NN benefit)) (VP (MD could) (ADVP (RB also)) (ADVP (RB potentially)) (VP (VB be) (VP (VBN gained) (PP (IN from) (S (VP (VBG using) (NP (NP (JJ artificial) (NN UV) (NNS rays)) (VP (VBN generated) (PP (IN by) (NP (JJ medical) (NNS devices))))))))))))) (, ,) (CC and) (S (NP (DT this)) (VP (VBZ is) (SBAR (WHNP (WP what)) (S (NP (NP (NNP Aytu)) (CC and) (NP (NNP Cedar) (HYPH -) (NNP Sinai))) (VP (VBP are) (VP (VBG hoping) (SBAR (S (VP (MD will) (VP (VB be) (ADVP (RB widely)) (VP (VBN implemented) (PP (IN around) (NP (DT the) (NN globe)))))))))))))) (. .)))
15: (ROOT (S ('' `) (NP (PRP We)) (VP (VBP are) (VP (VBN honored) (S (VP (TO to) (VP (VB be) (VP (VBG partnering) (PP (IN with) (NP (NNP Cedar) (HYPH -) (NNP Sinai))))))) (SBAR (IN as) (S (NP (PRP we)) (VP (VBP believe) (SBAR (S (NP (DT the) (NNP Healight) (JJ therapeutic) (NN platform)) (VP (VBZ has) (NP (DT the) (NN potential) (S (VP (TO to) (VP (VB help) (NP (JJ many) (NNS patients)) (PP (PP (IN during) (NP (DT this) (NN coronavirus) (NN pandemic))) (CC and) (ADVP (RB beyond))))))))))))))) (. .)))
16: (ROOT (SINV (S (S (NP (DT This) (NML (NNP firs) (HYPH -) (SYM i) (HYPH -) (NN class)) (NN technology)) (VP (VBZ has) (NP (DT the) (NN potential) (S (VP (TO to) (VP (VB be) (NP (NP (DT a) (NN game) (NN changer)) (PP (IN for) (NP (NP (NNS clinicians)) (VP (VBG treating) (NP (NP (NNS patients)) (VP (VBN infected) (PP (IN with) (NP (NP (NN coronavirus)) (CC and) (NP (JJ other) (JJ respiratory) (NNS conditions)))))))))))))))) (, ,) (CC and) (S (NP (PRP$ our) (NN team)) (VP (VBZ is) (VP (VBG working) (ADVP (RB tirelessly)) (PP (IN alongside) (NP (DT the) (NML (NNP Cedar) (HYPH -) (NNP Sinai)) (NN team))) (S (VP (TO to) (VP (VB determine) (NP (NP (DT the) (NN safety) (CC and) (NN effectiveness)) (PP (IN of) (NP (DT this) (NN device))) (PP (IN in) (NP (NNS humans))))))))))) (, ,) ('' ') (VP (VBZ says)) (NP (NP (NNP Josh) (NNP Disbrow)) (, ,) (NP (NP (NNP Chairman) (CC and) (NN CEO)) (PP (IN of) (NP (NNP Aytu) (NNP BioScience))))) (. .)))
